{"id":807697,"title":"Recommendation on the Use of Live Attenuated Influenza Vaccine (LAIV) in HIV-Infected Individuals - Canada.ca","sourceCode":"phac","sourceName":"Public Health Agency of Canada","language":"en","captureDate":"2026-03-02","captureTimestamp":"2026-03-02T13:35:16.497000+00:00","jobId":7,"originalUrl":"https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/live-attenuated-influenza-vaccine-hiv-infected-individuals.html","snippet":"Recommendation on the Use of Live Attenuated Influenza Vaccine (LAIV) in HIV-Infected Individuals An Advisory Committee Statement (ACS) | National Advisory Committee on Immunization (NACI) Preamble The National Advisory Committee on Immunization (NACI) provides the Public Health…","rawSnapshotUrl":"/api/snapshots/raw/807697","browseUrl":"https://replay.healtharchive.ca/job-7/20260302133516/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/live-attenuated-influenza-vaccine-hiv-infected-individuals.html#ha_snapshot=807697","mimeType":"text/html","statusCode":200,"captureBackend":"playwright_warc","captureFidelity":"fallback"}